What is IHHT?
“IHHT” stands for intermittent hypoxia–hyperoxia therapy or training. It alternates phases with reduced oxygen (hypoxia) and elevated oxygen (hyperoxia). The result is individually controllable cellular training focused on energy, recovery and metabolic adaptation.
Is hypoxia dangerous?
Hypoxia was long considered unhealthy and even dangerous. Conventional medicine avoids even brief oxygen undersupply, because oxygen underpins cellular energy metabolism—especially in the brain.
Severe acute hypoxia is regarded as dangerous because neurons depend on oxygen to survive; irreversible injury can occur within minutes, related to imbalances in cell and mitochondrial membranes.
Blood oxygen saturation remains a key monitoring parameter in intensive care. Away from acute life-threatening situations, however, controlled oxygen limitation has been used in sports performance for decades.
Classic altitude training is one example: athletes use lower inspired oxygen before competition to compete with greater capacity. A key mechanism is hypoxia-inducible factor 1-alpha (HIF-1α), which among other effects promotes erythropoietin (EPO) and red blood cell formation.
Research also suggests that intermittent, moderate hypoxia may differ from acute, life-threatening hypoxia and can have protective characteristics regarding membrane balance and neuronal electrical potential.
Nobel Prize in Physiology or Medicine
The 2019 Nobel Prize recognised scientists who clarified how cells sense and adapt to oxygen availability. Chronic hypoxia should still be avoided whenever possible. IHHT aims to offer a controlled, practical way to use hypoxia-related adaptation pathways safely.
How does IHHT work?
Intermittent hypoxia–hyperoxia therapy typically involves minimal physical exertion. Users lie on a couch or sit in a recliner and breathe gas mixtures with changing oxygen content through a mask.
Vital signs such as heart rate and oxygen saturation are monitored to support safety. Sessions use repeated intervals of hypoxia for several minutes, followed by compensatory hyperoxia. If saturation falls markedly, the hypoxic phase is stopped and a regenerative hyperoxic phase begins.
A typical session often lasts about 30–50 minutes. Phase intensity and duration are adjusted to the individual.
Metabolic adaptation and IHHT
IHHT is also discussed as cellular or mitochondrial training and is often considered where mitochondrial health is a focus—for example chronic fatigue, selected mitochondrial disorders or metabolic dysfunction.
It is also discussed in metabolic syndrome, prediabetes and type 2 diabetes, contexts where mitochondrial and metabolic imbalance are common. Mitochondria supply much of the cell's energy.
IHHT and metabolic syndrome
Metabolic syndrome affects a large share of adults and increases cardiovascular risk. Studies under IHHT have reported improvements in blood lipids, inflammatory markers and sometimes liver- and heart-related markers.
Other work describes effects on blood pressure and vascular stiffness. IHHT may therefore be a useful adjunct in prevention and secondary prevention—always as part of individual medical judgement.
Can IHHT support mitochondrial function?
Direct measurement of mitochondrial function in humans is complex. Researchers often use proxies such as oxidative stress, ATP availability, bioenergetic indices or lactate/pyruvate ratios.
Animal models indicate intermittent hypoxia training can affect oxidative phosphorylation and improve mitochondrial efficiency. In short, studies suggest IHT/IHHT may support mitochondrial energy production.
The therapeutic idea is also that functionally robust mitochondria respond better to alternating stimuli, triggering cellular adaptation that may relate to vitality, resilience and recovery.
IHHT systems from cellgym
Looking for an IHHT system for your practice or home? cellgym can help you integrate cellular training—with tailored advice and systems matched to your use case.
Request a non-binding consultation
References
- Serebrovskaya et al. (2013). Tissue oxygenation and mitochondrial respiration under different modes of intermittent hypoxia. High Altitude Medicine & Biology.
https://doi.org/10.1089/ham.2013.1012 - Afina et al. (2021). The Effects of Intermittent Hypoxic-Hyperoxic Exposures on Lipid Profile and Inflammation in Patients With Metabolic Syndrome. Frontiers in Cardiovascular Medicine.
https://doi.org/10.3389/fcvm.2021.700826 - Bestavashvili et al. (2022). Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome. Biomedicines.
https://doi.org/10.3390/biomedicines10030566